Proximity proteomics in a marine diatom reveals a putative cell surface-to-chloroplast iron trafficking pathway

  1. Jernej Turnšek
  2. John K Brunson
  3. Maria del Pilar Martinez Viedma
  4. Thomas J Deerinck
  5. Aleš Horák
  6. Miroslav Oborník
  7. Vincent A Bielinski
  8. Andrew Ellis Allen  Is a corresponding author
  1. University of California, Berkeley, United States
  2. University of California San Diego, United States
  3. J. Craig Venter Institute, United States
  4. National Center for Microscopy and Imaging Research, University of California San Diego, United States
  5. Czech Academy of Sciences, Czech Republic
  6. J Craig Venter Institute, United States

Abstract

Iron is a biochemically critical metal cofactor in enzymes involved in photosynthesis, cellular respiration, nitrate assimilation, nitrogen fixation, and reactive oxygen species defense. Marine microeukaryotes have evolved a phytotransferrin-based iron uptake system to cope with iron scarcity, a major factor limiting primary productivity in the global ocean. Diatom phytotransferrin is endocytosed, however proteins downstream of this environmentally ubiquitous iron receptor are unknown. We applied engineered ascorbate peroxidase APEX2-based subcellular proteomics to catalog proximal proteins of phytotransferrin in the model marine diatom Phaeodactylum tricornutum. Proteins encoded by poorly characterized iron-sensitive genes were identified including three that are expressed from a chromosomal gene cluster. Two of them showed unambiguous colocalization with phytotransferrin adjacent to the chloroplast. Further phylogenetic, domain, and biochemical analyses suggest their involvement in intracellular iron processing. Proximity proteomics holds enormous potential to glean new insights into iron acquisition pathways and beyond in these evolutionarily, ecologically, and biotechnologically important microalgae.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files

The following previously published data sets were used

Article and author information

Author details

  1. Jernej Turnšek

    Biological and Biomedical Sciences, University of California, Berkeley, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. John K Brunson

    Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Maria del Pilar Martinez Viedma

    Microbial and Environmental Genomics, J. Craig Venter Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Thomas J Deerinck

    National Center for Microscopy and Imaging Research, University of California San Diego, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Aleš Horák

    Institute of Parasitology, Biology Centre, Czech Academy of Sciences, České Budějovice, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  6. Miroslav Oborník

    Institute of Parasitology, Biology Centre, Czech Academy of Sciences, České Budějovice, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  7. Vincent A Bielinski

    Synthetic Biology and Bioenergy, J Craig Venter Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Andrew Ellis Allen

    Integrative Oceanography Division, Scripps Institution of Oceanography, University of California San Diego, La Jolla, United States
    For correspondence
    aallen@ucsd.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5911-6081

Funding

Gordon and Betty Moore Foundation (GBMF3828)

  • Andrew Ellis Allen

Gordon and Betty Moore Foundation (GBMF5006)

  • Andrew Ellis Allen

National Science Foundation (NSF-OCE-1756884)

  • Andrew Ellis Allen

National Science Foundation (NSF-MCB-1818390)

  • Andrew Ellis Allen

Biological and Environmental Research (DE-SC0018344)

  • Andrew Ellis Allen

Gordon and Betty Moore Foundation (GBMF4958)

  • Jernej Turnšek

National Institutes of Health (1F31ES030613-01)

  • John K Brunson

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Turnšek et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,807
    views
  • 380
    downloads
  • 18
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jernej Turnšek
  2. John K Brunson
  3. Maria del Pilar Martinez Viedma
  4. Thomas J Deerinck
  5. Aleš Horák
  6. Miroslav Oborník
  7. Vincent A Bielinski
  8. Andrew Ellis Allen
(2021)
Proximity proteomics in a marine diatom reveals a putative cell surface-to-chloroplast iron trafficking pathway
eLife 10:e52770.
https://doi.org/10.7554/eLife.52770

Share this article

https://doi.org/10.7554/eLife.52770

Further reading

    1. Medicine
    2. Microbiology and Infectious Disease
    Berit Siedentop, Viacheslav N Kachalov ... Sebastian Bonhoeffer
    Research Article

    Background:

    Under which conditions antibiotic combination therapy decelerates rather than accelerates resistance evolution is not well understood. We examined the effect of combining antibiotics on within-patient resistance development across various bacterial pathogens and antibiotics.

    Methods:

    We searched CENTRAL, EMBASE, and PubMed for (quasi)-randomised controlled trials (RCTs) published from database inception to 24 November 2022. Trials comparing antibiotic treatments with different numbers of antibiotics were included. Patients were considered to have acquired resistance if, at the follow-up culture, a resistant bacterium (as defined by the study authors) was detected that had not been present in the baseline culture. We combined results using a random effects model and performed meta-regression and stratified analyses. The trials’ risk of bias was assessed with the Cochrane tool.

    Results:

    42 trials were eligible and 29, including 5054 patients, qualified for statistical analysis. In most trials, resistance development was not the primary outcome and studies lacked power. The combined odds ratio for the acquisition of resistance comparing the group with the higher number of antibiotics with the comparison group was 1.23 (95% CI 0.68–2.25), with substantial between-study heterogeneity (I2=77%). We identified tentative evidence for potential beneficial or detrimental effects of antibiotic combination therapy for specific pathogens or medical conditions.

    Conclusions:

    The evidence for combining a higher number of antibiotics compared to fewer from RCTs is scarce and overall compatible with both benefit or harm. Trials powered to detect differences in resistance development or well-designed observational studies are required to clarify the impact of combination therapy on resistance.

    Funding:

    Support from the Swiss National Science Foundation (grant 310030B_176401 (SB, BS, CW), grant 32FP30-174281 (ME), grant 324730_207957 (RDK)) and from the National Institute of Allergy and Infectious Diseases (NIAID, cooperative agreement AI069924 (ME)) is gratefully acknowledged.

    1. Microbiology and Infectious Disease
    Dipasree Hajra, Raju S Rajmani ... Dipshikha Chakravortty
    Research Article

    Sirtuins are the major players in host immunometabolic regulation. However, the role of sirtuins in the modulation of the immune metabolism pertaining to salmonellosis is largely unknown. Here, our investigation focussed on the role of two important sirtuins, SIRT1 and SIRT3, shedding light on their impact on intracellular Salmonella’s metabolic switch and pathogenesis establishment. Our study indicated the ability of the live Salmonella Typhimurium to differentially regulate the levels of SIRT1 and SIRT3 for maintaining the high glycolytic metabolism and low fatty acid metabolism in Salmonella. Perturbing SIRT1 or SIRT3 through knockdown or inhibition resulted in a remarkable shift in the host metabolism to low fatty acid oxidation and high glycolysis. This switch led to decreased proliferation of Salmonella in the macrophages. Further, Salmonella-induced higher levels of SIRT1 and SIRT3 led to a skewed polarization state of the macrophages from a pro-inflammatory M1 state toward an immunosuppressive M2, making it more conducive for the intracellular life of Salmonella. Alongside, governing immunological functions by modulating p65 NF-κB acetylation, SIRT1, and SIRT3 also skew Salmonella-induced host metabolic switch by regulating the acetylation status of HIF-1α and PDHA1. Interestingly, though knockdown of SIRT1/3 attenuated Salmonella proliferation in macrophages, in in vivo mice model of infection, inhibition or knockdown of SIRT1/3 led to more dissemination and higher organ burden, which can be attributed to enhanced ROS and IL-6 production. Our study hence reports for the first time that Salmonella modulates SIRT1/3 levels to maintain its own metabolism for successful pathogenesis.